Free tool
FDA Clearance Tracker
Last checked: Nov 20, 2026Latest source record: Nov 8, 2026 (newest decision)openFDA last updated: Nov 9, 2026Methods & limitations
Filters
Filters are saved in the page address, so a filtered view can be bookmarked or shared.
Product code QJZ: Extracorporeal System For Long-Term Respiratory / Cardiopulmonary Failure. Open this device type's page
4 decisions
product code QJZ. Showing 1 to 4, newest first. PMA results are original approvals and panel-track supplements.
K261335 · Decided Jul 31, 2026 · 99 days after receipt
Device type: Extracorporeal System For Long-Term Respiratory / Cardiopulmonary Failure (QJZ) · Cardiology
K240880 · Decided Sep 12, 2024 · 164 days after receipt
Device type: Extracorporeal System For Long-Term Respiratory / Cardiopulmonary Failure (QJZ) · Cardiology
Fresenius Medical Care Renal Therapies Group, LLC
K232926 · Decided Apr 15, 2024 · 208 days after receipt
Device type: Extracorporeal System For Long-Term Respiratory / Cardiopulmonary Failure (QJZ) · Cardiology
1 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.